The Food and Drug Administration on Thursday approved Journavx, a non-opioid painkiller that is the first novel pain drug to win government authorization in more than 20 years. Vertex ...
The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.
For the first time in more than 25 years, the U.S. Food and Drug Administration has signed off on a new type of pain reliever ...
A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...
The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...
The first shot taken at Medicaid, likely UnitedHealthcare coverage for Vertex's pain drug, and Optum’s wellness visit ad.
These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...
A new painkiller was approved by the Food and Drug Administration (FDA) on Thursday, and is one step closer to making its way ...
The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr.
Axios Vitals on MSN19h
FDA approves Vertex non-opioid pain drugThe FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why ...
While it's next to impossible to know how many opioids entered the state illegally in 2023, we do know that just under 1.7 ...
Journavx is the first new type of pain reliever approved by the FDA to hit the market in more than two decades. Emory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback